Frequent and simultaneous aberrant methylation of genes implicated in TP53 pathway indicates that, although indirectly and against previous knowledge, TP53 is altered in a high percentage of ALL patients, as it is the case in other types of cancer. The gene discussed is TP53; the disease is cancer.